| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 03/09/2005 | EP1512397A1 O-substituted hydroxyaryl derivatives |
| 03/09/2005 | EP1511728A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
| 03/09/2005 | EP1511721A2 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 03/09/2005 | EP1511710A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer s disease, type 2 diabetes, and parkinson s disease |
| 03/09/2005 | EP1511704A1 Polymerisation inhibitor |
| 03/09/2005 | EP1307440B1 2,2-disubstituted 1,3-dioxolanes as antitussive agents |
| 03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 03/09/2005 | EP1018008B1 Method of identification of leads or active compounds |
| 03/09/2005 | CN1592740A Process for the synthesis of amine ethers from secondary amino oxides and its use |
| 03/09/2005 | CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds |
| 03/08/2005 | US6864392 α-Sulfin and α-Sulfonamino amide derivatives |
| 03/08/2005 | US6864286 2-cyano-3-hydroxy-p-(trifluoromethoxy)crotonanilide |
| 03/08/2005 | US6864285 Hypotensive agents; antihistamines; immunology moderators; antiinflammatory agents |
| 03/08/2005 | US6864262 Bladder disorders; incontinence; side effect reduction |
| 03/03/2005 | WO2005019240A2 Melanin concentrating hormone receptor antagonists |
| 03/03/2005 | WO2005019194A1 Derivatives of hydroxamic acid as metalloproteinase inhibitors |
| 03/03/2005 | WO2005019193A2 Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk) |
| 03/03/2005 | WO2005019147A2 Pesticidally active phenol derivatives |
| 03/03/2005 | WO2005018643A1 Metabolites of 1-{3-4`4-(2-methoxyphenyl) piperazin-1-yl!-propyl}-piperidine-2, 6-dione for use in the treatment of benign prostatic hyperplasia |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | WO2004101581A3 Nitrogen-containing monodentate phosphines and their use in catalysis |
| 03/03/2005 | WO2004101540A3 Method for the production of phenylacetic acid derivatives |
| 03/03/2005 | WO2004050647A8 Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof |
| 03/03/2005 | US20050049429 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis |
| 03/03/2005 | US20050049310 Aryl and heteroaryl compounds, compositions and methods of use |
| 03/03/2005 | US20050049254 Substituted heterocyclic compounds |
| 03/03/2005 | US20050049239 Type 2 glycine transporter inhibitors; muscle spasticity, tinnitus, epilepsy neuropathic pain, obesity |
| 03/03/2005 | US20050049235 Amino ceramide-like compounds and therapeutic methods of use |
| 03/03/2005 | US20050049146 E.g., 7-fluoro-10-(4-ethylpiperazine)-dibenzo(b,f)thiepine as well as analogues based on dibenzo(b,f)oxepin, dibenzo(b,f)azepin and dibenzo(a,d)cycloheptene; parasiticides; pesticides; protecting crops; along with an agronomically acceptable carrier |
| 03/03/2005 | DE10336186A1 Sulfonamid-Anionen als Katalysatoren für die NCO-Oligomerisierung Sulfonamide anions as catalysts for the NCO oligomerization |
| 03/02/2005 | EP1510515A1 Phenylglycine derivatives as serine protease inhibitors |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509495A1 Anilino liver x-receptor modulators |
| 03/02/2005 | EP1509484A2 Process for preparing vinylaromatic compounds |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | CN1191248C 1-(2-naphthyl) and 1(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine D4 receptor subtype lignds |
| 03/01/2005 | US6861556 For example, 1-(2-(3-hydroxy-4-methyl-phenylamino)-ethyl)-3 methyl 3-H-imidazol-1-ium chloride; prepared by reacting an aminophenol with a haloacetyl chloride, reducing product with borane-tetrahydrofuran complex, reacting compound with amine |
| 03/01/2005 | US6861536 Increased enantioselectivity of asymmetric addition of organic zinc and aldehyde by providing ligands to perform as superior catalysts to form a predominance of secondary alcohol; efficiency |
| 03/01/2005 | US6861435 3-(amino-imino-methyl)benzyl derivatives with an amide -n-sulfonylamido on the methyl of the benzyl |
| 03/01/2005 | US6861424 A piperazine compound as antithrombotic agent |
| 03/01/2005 | US6861106 Dichroic dye, composition thereof, and liquid crystal composition and liquid crystal display element containing the same |
| 02/24/2005 | WO2005017037A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | WO2005016902A1 N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 02/24/2005 | WO2005016901A1 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/24/2005 | WO2005016900A1 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016344A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | WO2005016264A2 Diamine derivatives of quinone and uses thereof |
| 02/24/2005 | US20050043532 Dehydration, dehydrosulfurization or deamination and ring closure of aqueous bis(2-hydroxyethyl)ethers, amines, or sulfides, bis(2-mercaptoethyl)ethers, amines, or sulfides, and bis(2-aminoethyl)ethers, amines or sulfides by heating under autogeneous pressure |
| 02/24/2005 | US20050043397 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 02/24/2005 | US20050043388 Therapy, prevention of metabolism disorders; insulin resistance; antidiabetic agents; hypoglycemic agents; anticholesterol agents; obesity; polycystic ovarian syndrome |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050043300 Piperazine derivatives |
| 02/24/2005 | US20050043299 Inhibitors of dipeptidyl peptidase iv |
| 02/24/2005 | US20050043295 Pharmaceutically effective compounds |
| 02/24/2005 | DE10302452B4 Carbonylamino-substituierte Acyl-phenyl-harnstoffderivate, Verfahren zu deren Herstellung und deren Verwendung Carbonylamino-substituted acyl-phenyl-urea derivatives, processes for their preparation and their use |
| 02/24/2005 | CA2536073A1 Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2534866A1 Piperazine derivatives for the treatment of hiv infections |
| 02/24/2005 | CA2534850A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 02/24/2005 | CA2529750A1 N-phenyl-piperazine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 02/23/2005 | EP1507504A1 Cycloalkyl inhibitors of potassium channel function |
| 02/23/2005 | EP1226128B1 New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585755A Benzamide and heteroarylamide as P2X7 receptor antagonists |
| 02/23/2005 | CN1585746A Beta-amyloid protein production/secretion inhibitors |
| 02/23/2005 | CN1585742A Aryl aniline beta-2 adrenergic receptor agonists |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | US6858600 Used for inhibiting the interaction of an alpha-helical protein with another protein or binding site; for therapy of diseases |
| 02/22/2005 | US6858434 Using thin layer chromatography for rapid preparation and screening of lead structures for drug candidates; rational drug design |
| 02/22/2005 | US6858210 For inducing tolerance in an individual; bind to anti-cardiolipin ( beta 2GPI-dependent antiphospholipid) |
| 02/17/2005 | WO2005014563A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | WO2005014534A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/17/2005 | WO2005014533A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/17/2005 | WO2005014532A1 Aryl and heteroaryl compounds, compositions and methods of use |
| 02/17/2005 | WO2005014515A2 Clear photopolymerizable systems for the preparation of high thickness coatings |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004080391A3 Novel antibacterial agents |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | WO2003080568A3 Probucol derivatives |
| 02/17/2005 | US20050038117 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity |
| 02/17/2005 | US20050038081 amidation of a heteroary substituted oxoaminobenzoic acid with an amine; for treatment of psoriasis and rheumatoid arthritis using e.g. N-(3-dimethylaminophenyl)-3-(3-methoxybenzamido)-4-methylbenzamide |
| 02/17/2005 | US20050038037 N-(naphth-2-ylaminocarbonylacetyl)- or N-(naphth-2-ylcarbonylamino- acetyl)- piperazine derivatives, e.g., 2-[((4-(ethoxycarbonyl)piperazin-1-yl)carbonylmethyl)carbonyl]aminonaphthalene; useful as antithrombotic agents |
| 02/17/2005 | US20050038035 Heterocyclic amide compounds as apolipoprotein b inhibitors |
| 02/17/2005 | US20050038034 Analgesics; neurodegenerative disorders; multiple sclerosis; Parkinson's disease; neuropathic pain |
| 02/17/2005 | US20050038020 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
| 02/17/2005 | US20050038014 5'-carbamoyl-1,1' biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 02/17/2005 | US20050038002 Bactericides; antitumor agents; moderators of gene expression; viricides; parasiticides; malaria therapy |
| 02/17/2005 | US20050037934 Hair conditioner; flexibility; smoothness |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | CA2534675A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 02/17/2005 | CA2531796A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/16/2005 | EP1506169A1 Method for the production of sulphamic acid halogenides |
| 02/16/2005 | EP1506158A2 Diamino-functional chalcones |
| 02/16/2005 | EP1506157A2 Amino-functional chalcones |
| 02/16/2005 | EP1505977A2 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |